Press Releases
-
Alfa Chemistry Announces the Launch of Innovative IVD Products for Laboratory Use
-
CD BioGlyco Releases One-Stop Services for Glycoprotein-Based Vaccine Development
-
Samsung Biologics and Kurma Partners announce strategic partnership for development and manufacturing of biologics for Kurma’s portfolio companies
-
Creative Biolabs Unveils ADC Services, Igniting Excitement in the Biotech Industry
Creative Biolabs, a prominent provider of groundbreaking biotechnology solutions, proudly announced the expansion of its antibody-drug conjugate (ADC) business with the introduction of novel services.
Oct 22, 2023
-
Creative Enzymes Unveils the Creative SuperCut Series: Redefining Precision in Molecular Biology
-
Creative Enzymes Unveils Advanced Substrate, Inhibitor, and Ligand Screening Services
-
Andelyn Biosciences and Purespring Therapeutics Partner to Manufacture Novel Gene Therapies for Kidney Diseases
Andelyn Biosciences, a gene therapy CDMO, has joined forces with Purespring Therapeutics to accelerate the development of gene therapies for chronic kidney diseases. Purespring is known for its innovative treatments that can slow or halt these diseases. The partnership leverages Andelyn's AAV production expertise and suspension platform under GMP to expedite the clinical advancement of Purespring's therapies. Both organizations share a commitment to improving human health through gene therapies. This collaboration will benefit from Andelyn's advanced GMP manufacturing capabilities in Columbus, Ohio, and is poised to offer hope to patients with kidney diseases.
Oct 19, 2023
-
Empowering Research Excellence: Alfa Chemistry's THEIC, D-Pantethine, and Methoxytriethyleneoxypropyltrimethoxysilane at the Forefront
-
BOC Sciences at TIDES Europe 2023: Key Chemicals and XDC Platform to Be Exhibited
BOC Sciences will attend "TIDES Europe: Oligonucleotide & Peptide Therapeutics", delivered as a hybrid event from 30 Oct - 1 Nov 2023, in Amsterdam, NL. Its high-yield nucleosides & nucleotides, as well as a newly launched XDC platform, will be exhibited in front of the industry.
Oct 18, 2023
-
Cresset Targets International Growth with Innovate UK Scaleup Programme
Drug discovery specialists Cresset has joined Innovate UK’s Scaleup Programme for businesses with high growth potential
Oct 18, 2023
-
CD Formulation's Scientists Share A Holistic Approach on How to Prepare Drug Microcapsules
-
CD Genomics Revolutionizes TCR-Seq Elevating Immune Repertoire Profiling to New Heights
-
CD Genomics Unveils Cutting-Edge CRISPR Screen Sequencing Technology
-
CD Genomics Introduces Cutting-Edge Degradome Sequencing Service Redefining Transcriptomics Research
-
JPA HEALTH EXPANDS LIFE SCIENCES DIVISION WITH ACQUISITION OF TRUE NORTH SOLUTIONS, INC.
Addition brings together synchronized experts to offer comprehensive predictive analytics, data visualization and AI-driven end-to-end solutions for life sciences, government and non-profit organizations
Oct 17, 2023
-
Inizio Engage launches new global powerhouse learning brand, Nazaré
-
Biotium Introduces New Highly-Selective Stains For Both Gram-Positive and Gram-Negative Bacteria
Biotium has announced the launch of its breakthrough BactoView™ Dead Stains and BactoView™ Viability Kits.
Oct 17, 2023
-
Avania Bolsters MedTech CRO Value Chain Capabilities With Two Acquisitions in Highly Strategic Areas of Engineering Design & Product Development and Market Access
Avania, a leading, global medical technology contract research organization (CRO), today announced its acquisition of HULL ASSOCIATES LLC and Ironstone Product Development (IPD) with a view toward addressing MedTech’s emerging priorities in regulatory and reimbursement and building scale to offer thoughtful strategies and differentiated project delivery for all product categories.
Oct 16, 2023
-
Quotient Sciences Appoints Thierry Van Nieuwenhove as New CEO
-
Expanding Research Horizons: CD Formulation Unveils its Redesigned Collection of Pharmaceutical Excipients